NALOXONE HYDROCHLORIDE (AUTOINJECTOR)
Peaknaloxone hydrochloride
NDAINTRAMUSCULAR, SUBCUTANEOUSSOLUTIONPriority Review
Approved
Feb 2022
Lifecycle
Peak
Competitive Pressure
0/100
Mechanism of Action
sites. Naloxone HCl reverses the effects of opioids, including respiratory depression, sedation, and hypotension. Also, it can reverse the psychotomimetic and dysphoric effects of agonist-antagonists such as pentazocine.
Indications (1)
Loss of Exclusivity
LOE Date
May 24, 2031
63 months away
Patent Expiry
May 24, 2031